Md Ashraf-Uz-Zaman

Mr. Md Ashraf-Uz-Zaman

Texas Tech Health Sciences Center

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Md Ashraf-Uz-ZamanMd Ashraf-Uz-Zaman
Md Ashraf-Uz-Zaman
ABAditya Bhalerao
Aditya Bhalerao
CMConstantinos M. Mikelis
Constantinos M. Mikelis
Luca CuculloLuca Cucullo
Luca Cucullo
NGNadezhda German
Nadezhda German
Chemoprevention of lung cancer is thought to significantly reduce the risk of acquiring these conditions in the subpopulation of patients with underlying health issues, such as chronic obstructive pulmonary disorder and smoking-associated lung problems. Many strategies have been tested in the previous decades, with very few translating to successful clinical trials in specific subpopulations of patients. In this review, we analyze these strategies, as well as new approaches that have emerged throughout the last few years, including synthetic lethality concept and microbiome-induced regulation of lung carcinogenesis. Overall, the continuous effort in the area of lung chemoprevention is required to develop practical therapeutical approaches. Given the inconsistency of results obtained in clinical trials targeting lung cancer chemoprevention in various subgroups of patients that differ in the underlying health condition, race, and gender, we believe that individualized approaches will have more promise than generalized treatments.